Funders’ Role in Ophthalmic Artificial Intelligence Innovations

This Viewpoint outlines the entities who have been funding ophthalmic artificial intelligence (AI) innovations in the past 5 years and considers what this shifting balance of power in funding might mean for the next wave of foundation AI models and clinical translation.

Corresponding Author: T. Y. Alvin Liu, MD, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 N Wolfe St, Maumenee 726, Baltimore, MD 21287 (tliu25@jhmi.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.